TAFFA N TMUSNIWIN TUSNANIN

2022 Consensus Statement on Minimally Invasive Procedures for Benign and Malignant Thyroid Lesions

American Association of Clinical EndocrinologyTasleḍt n tfeggagin d ssker2022Asuffeɣ unṣib

Agzul n yisemli ASEM

Official American Association of Clinical Endocrinology document (2022) on “2022 Consensus Statement on Minimally Invasive Procedures for Benign and Malignant Thyroid Lesions”. This consensus statement provides information on novel minimally invasive therapeutic interventions for thyroid malignancies such as percutaneous ethanol injection and thermal ablation. The statement summarizes existing knowledge and provides guidance on indications, techniques, complications, and follow-ups for care of patients with benign and malignant thyroid lesions. DOI: 10.1016/j.eprac.2022.02.011.

Agzul-a ad k-yefk tallalt deg unadi ɣef uttaft. I wellihen klinik, ẓer yal tikkelt lqem unṣib amiran akked uzemz n uleqqem-is.

Isemli unṣib